Inozyme Pharma, Inc. Announces Pricing of Public Offering of Common Stock

BOSTON, July 27, 2023 -- Inozyme Pharma, Inc. , a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal...

Related Keywords

Boston ,Massachusetts ,United States ,New York ,Minnesota ,Wedbush Pacgrow ,Stefan Riley ,Matt Pera ,Piper Sandler ,Inozyme Pharma ,Prospectus Department ,Needham Company ,Globenewswire Inc ,Corporate Communications ,Exchange Commission ,Inozyme Pharma Inc ,Nasdaq ,Tryon Street ,Private Securities Litigation Reform Act ,Markets ,